U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Renal cell carcinoma, usually clear cell type

MedGen UID:
814822
•Concept ID:
C3808492
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRenal cell carcinoma, usually clear cell type

Professional guidelines

PubMed

Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article
Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ, Cazorla A, Manzarbeitia F
Urol Oncol 2011 Sep-Oct;29(5):545-9. Epub 2009 Nov 19 doi: 10.1016/j.urolonc.2009.07.024. PMID: 19926310
Genotype-phenotype correlation in von Hippel-Lindau syndrome.
Friedrich CA
Hum Mol Genet 2001 Apr;10(7):763-7. doi: 10.1093/hmg/10.7.763. PMID: 11257110

Recent clinical studies

Etiology

Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma.
Yu L, Ding L, Wang ZY, Zhao XZ, Wang YH, Liang C, Li J
J Healthc Eng 2022;2022:1147545. Epub 2022 Dec 21 doi: 10.1155/2022/1147545. PMID: 36591111Free PMC Article
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM
Int J Mol Sci 2021 Mar 11;22(6) doi: 10.3390/ijms22062832. PMID: 33799514Free PMC Article
Papillary Renal Cell Carcinoma (PRCC): An Update.
Akhtar M, Al-Bozom IA, Al Hussain T
Adv Anat Pathol 2019 Mar;26(2):124-132. doi: 10.1097/PAP.0000000000000220. PMID: 30507616
Renal tumors in end-stage renal disease: A comprehensive review.
Tsuzuki T, Iwata H, Murase Y, Takahara T, Ohashi A
Int J Urol 2018 Sep;25(9):780-786. Epub 2018 Jul 31 doi: 10.1111/iju.13759. PMID: 30066367
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article

Diagnosis

Renal Neoplasms in Young Adults.
Gopee-Ramanan P, Chin SS, Lim C, Shanbhogue KP, Schieda N, Krishna S
Radiographics 2022 Mar-Apr;42(2):433-450. doi: 10.1148/rg.210138. PMID: 35230920
Immunohistochemistry for the diagnosis of renal epithelial neoplasms.
Akgul M, Williamson SR
Semin Diagn Pathol 2022 Jan;39(1):1-16. Epub 2021 Nov 12 doi: 10.1053/j.semdp.2021.11.001. PMID: 34823973
Renal tumors in end-stage renal disease: A comprehensive review.
Tsuzuki T, Iwata H, Murase Y, Takahara T, Ohashi A
Int J Urol 2018 Sep;25(9):780-786. Epub 2018 Jul 31 doi: 10.1111/iju.13759. PMID: 30066367
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article
von Hippel-Lindau syndrome.
Chou A, Toon C, Pickett J, Gill AJ
Front Horm Res 2013;41:30-49. Epub 2013 Mar 19 doi: 10.1159/000345668. PMID: 23652669

Therapy

Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life).
Kaddissi AE, Ducleon GG, Lefort F, Mezepo G, Frontczak A, Goujon M, Mouillet G, Almotlak H, Gross-Goupil M, Thiery-Vuillemin A
Bull Cancer 2022 May;109(2S):2S19-2S30. doi: 10.1016/S0007-4551(22)00235-1. PMID: 35760467
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM
Int J Mol Sci 2021 Mar 11;22(6) doi: 10.3390/ijms22062832. PMID: 33799514Free PMC Article
Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma.
D'Costa NM, Cina D, Shrestha R, Bell RH, Lin YY, Asghari H, Monjaras-Avila CU, Kollmannsberger C, Hach F, Chavez-Munoz CI, So AI
Sci Rep 2020 Feb 6;10(1):2026. doi: 10.1038/s41598-020-58804-y. PMID: 32029828Free PMC Article
Impact of the Type of Analgesic Therapy on Postsurgical Complications of Patients with Kidney Cancer Undergoing Nephrectomy.
Varela-Santoyo E, Escamilla-López MI, Izquierdo-Tolosa CD, Arroyave-Ramírez AM, Buerba-Vieregge HH, Dorantes-Heredia R, Motola-Kuba D, Ruiz-Morales JM
Oncology 2020;98(2):117-122. Epub 2019 Nov 12 doi: 10.1159/000504258. PMID: 31715614
Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option.
Smolle E, Taucher V, Petru E, Haybaeck J
Anticancer Res 2014 Apr;34(4):1519-30. PMID: 24692678

Prognosis

Renal Neoplasms in Young Adults.
Gopee-Ramanan P, Chin SS, Lim C, Shanbhogue KP, Schieda N, Krishna S
Radiographics 2022 Mar-Apr;42(2):433-450. doi: 10.1148/rg.210138. PMID: 35230920
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM
Int J Mol Sci 2021 Mar 11;22(6) doi: 10.3390/ijms22062832. PMID: 33799514Free PMC Article
Papillary Renal Cell Carcinoma (PRCC): An Update.
Akhtar M, Al-Bozom IA, Al Hussain T
Adv Anat Pathol 2019 Mar;26(2):124-132. doi: 10.1097/PAP.0000000000000220. PMID: 30507616
Renal tumors in end-stage renal disease: A comprehensive review.
Tsuzuki T, Iwata H, Murase Y, Takahara T, Ohashi A
Int J Urol 2018 Sep;25(9):780-786. Epub 2018 Jul 31 doi: 10.1111/iju.13759. PMID: 30066367
Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N, Ohe C, Mikami S, Inoue K, Nagashima Y, Cohen RJ, Pan CC, Michal M, Hes O
Histol Histopathol 2012 Aug;27(8):969-74. doi: 10.14670/HH-27.969. PMID: 22763870

Clinical prediction guides

Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma.
Yu L, Ding L, Wang ZY, Zhao XZ, Wang YH, Liang C, Li J
J Healthc Eng 2022;2022:1147545. Epub 2022 Dec 21 doi: 10.1155/2022/1147545. PMID: 36591111Free PMC Article
High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10.
Ma W, Li X, Yang L, Pan J, Chen Y, Lu Y, Dong X, Li D, Gan W
J Transl Med 2022 Dec 3;20(1):554. doi: 10.1186/s12967-022-03772-2. PMID: 36463181Free PMC Article
Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N, Sugawara E, Ohe C, Kojima F, Ohashi R, Mikami S, Nagashima Y, Peckova K, Michal M, Hes O
Pol J Pathol 2021;72(3):197-199. doi: 10.5114/pjp.2021.111769. PMID: 35048631
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM
Int J Mol Sci 2021 Mar 11;22(6) doi: 10.3390/ijms22062832. PMID: 33799514Free PMC Article
Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma.
Ortiz-Rey JA, Fachal C, Juaneda-Magdalena L, Muñoz-Martín M, Repáraz-Andrade A, Teijeira S, Lamas-Barreiro JM, Almuster-Domínguez S, San Miguel-Fraile P, Gómez-de María C
Virchows Arch 2021 Jul;479(1):57-67. Epub 2021 Jan 14 doi: 10.1007/s00428-021-03018-4. PMID: 33447899

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...